ATLANTA, Dec. 1, 2017 /PRNewswire/ -- CryoLife, Inc.
(NYSE: CRY), a leading medical device and tissue processing company
focused on cardiac and vascular surgery, announced today that it
has completed its previously announced acquisition of JOTEC AG, a
German-based, privately-held developer of technologically
differentiated endovascular stent grafts, and cardiac and vascular
surgical grafts, focused on aortic repair.
About CryoLife
Headquartered in suburban Atlanta,
Georgia, CryoLife is a leader in the manufacturing,
processing, and distribution of medical devices and implantable
living tissues used in cardiac and vascular surgical
procedures. CryoLife markets and sells a highly competitive
product portfolio focused on treating aortic disease in more than
80 countries worldwide. For additional information about
CryoLife, visit our website, www.cryolife.com.
|
Contacts:
|
|
|
|
|
CryoLife
D. Ashley
Lee
Executive Vice
President, Chief Financial Officer and
Chief Operating Officer
Phone: 770-419-3355
|
The Ruth
Group
Zack Kubow
646-536-7020
zkubow@theruthgroup.com
|
View original content with
multimedia:http://www.prnewswire.com/news-releases/cryolife-completes-acquisition-of-jotec-300565402.html
SOURCE CryoLife, Inc.